🇺🇸 FDA

Drug profile · INN

fingolimod

FINGOLIMOD MYLAN

approved L04AA27
US status
approved
Patents linked
2
News articles
0

Quick answer

fingolimod (FINGOLIMOD MYLAN) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN fingolimod
Brand FINGOLIMOD MYLAN
Route ORAL
Formulation CAPSULE
ATC code L04AA27

Related patents

Search patents →

Frequently asked questions

What is fingolimod?

fingolimod (FINGOLIMOD MYLAN) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for fingolimod?

FINGOLIMOD MYLAN is a marketed brand name for fingolimod. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of fingolimod?

fingolimod has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.